Peter Attia· MD
right nowadays because we go so low and and slow it's a very rare percent so about 1 in 10,000 or in some clinical trials one in 100,000 it's rare so that's good
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
right nowadays because we go so low and and slow it's a very rare percent so about 1 in 10,000 or in some clinical trials one in 100,000 it's rare so that's good
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.